Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 686 results for "drl"

NSE Nifty soars to new record, hits 9,000-mark for first time; BSE Sensex closes up 134 pts
Financial Express

Sensex, Nifty continue to fall; HDFC, DRL extend losses

Bears continued to keep tight control on Dalal Street as the Sensex fell 156.82 points to 27281.12 and the Nifty declined 60.95 points to 8244.30. Pharma, capital goods, FMCG and select banking financials led the fall today. Money Control, 3 hours ago

70 images for drl

CBC, 1 week ago
ThomasNet, 6 days ago, 1 week ago, 1 week ago, 1 week ago, 1 week ago, 1 week ago
MSN News US, 2 weeks ago, 2 weeks ago
The Telegraph, 3 weeks ago

DRL, Promius Pharma files NDAs with US FDA

Dr Reddy's Laboratories and its subsidiary, Promius Pharma announced the filing of three 505(b)(2) New Drug Applications (NDAs) with the US Food and Drug Administration (US FDA). The three NDAs DFD-01, DFD-09, and DFN-11, are in support of Dr ...
 Financial Express6 days ago Dr Reddy's Laboratories files 3 new drug applications in US  Deccan Chronicle2 weeks ago DRL opens formulation development laboratory  Financial Express1 month ago DRL to expand capacity of manufacturing units in Telangana  Business Standard2 months ago
The Telegraph

Eye significant growth in acquired UCB drugs: Dr Reddy's

According to Alok Sonig of DRL, the acquired brands have grown historically at lower double-digits and have a lot of headroom to grow further
 Money Control2 weeks ago Buy DRL as UCB buy incrementally positive  Financial Express2 weeks ago DRL to buy UCB brands for Rs 800 crore  Times of India3 weeks ago DRL buys Belgian UCB's select brands in India  Times of India3 weeks ago

DRL discloses robust product pipeline: Nomura

Dr Reddy's Laboratories (DRL) has disclosed that it has made three NDA filings with the US FDA, more than its earlier indications for 1-2 NDA filings by end-FY15. Unlike ANDAs, the timeline for approval of NDAs is shorter, hence approval can come ...
 Financial Express2 weeks ago DRL and its subsidiary Promius Pharma files three NDAs with US FDA  Financial Express2 weeks ago

DRL to acquire select portfolio of UCB's products business in India

The revenues of the acquired business is approximately Rs 150 crores for calendar year 2014 Dr Reddy's Laboratories (DRL) has entered into a definitive agreement to acquire a select portfolio of the established products business of UCB, in the ...
 Financial Express3 weeks ago DRL in Talks to acquire UCB India Business for $135 m  New Indian Express1 month ago DrL in talks to buy Belgian UCB India business for $135 million  Asian Age1 month ago Ireland in talks to lure indian drug companies with tax sops  4 Traders2 months ago

Dr Reddy's enters into partnership with Hetero

Dr Reddy's Laboratories (DRL) has entered into an agreement with Hetero, under which DRL has been licensed to distribute and market Sofosbuvir 400 mg tablets, indicated in the treatment of Chronic Hepatitis C, under the brand name Resof, in India. ...
 Indian-Commodity1 month ago DRL in partnership with Hetero  Financial Express1 month ago Dr Reddy Laboratories : TO LAUNCH HEPATITIS C DRUG IN INDIA  4 Traders1 month ago Dr Reddy's Lab gains after entering into partnership with Hetero  Capital Market1 month ago

Sensex volatile, Midcap outperforms; Bharti, DRL up 1.5%

The market remained in a consolidation mode for the second consecutive session today. The Sensex declined 11.71 points to 27945.78 and the Nifty slipped 9.20 points to 8481.80 while the broader markets outperformed benchmarks.
 Money Control3 weeks ago
Med India

Generic Sofosbuvir Pills for Sale in India to Treat Hepatitis C

Dr. Reddy's Laboratories Ltd (DRL), the country's second largest drug maker, has tied up with Hetero Drugs to sell the generic Sofosbuvir tablets (400mg) in India. The drug will make a significant difference in the diagnosis and treatment of Hepatitis C. "The ...
 Med India1 month ago DRL In Pact with Hetero to Sell Hepatitis C Drug  New Indian Express1 month ago Reddy's and Hetero to Sell Drugs for Hepatitis C  INooz1 month ago Dr Reddy's confident of 20% growth from UCB's drugs: Alok Sonig  India Infoline2 weeks ago
Money Control

DRL's drug pricing under scanner in US

Attorney Generals of Texas and California have separately sought information on pricing of some drugs sold by Dr Reddy's Laboratories in the US, according to the latest filing for the drug maker with SEC. The development comes after two members ...
 The Echo Of India1 month ago DRL faces US probe on pricing  The Telegraph2 months ago DR REDDY LABORATORIES : under US scanner  4 Traders1 month ago AGs of Texas, California probe DRL's drug pricing mechanism  The Financial Chronicle2 months ago

Sensex halves gains; Infosys drags, DRL Hindalco rally

The market trimmed its gains in noon trade. The 30-share BSE Sensex rose 159.62 points to 28597.33 and the Nifty climbed 44.85 points to 8678. About 1377 shares have advanced, 1073 shares declined, and 198 shares are unchanged on the BSE.
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less